You are here: Industry Insights > Generic

News List

Teva Announces Philadelphia-Area Layoffs americanpharmaceuticacreview
January 23, 2018
Teva Pharmaceuticals will lay off 208 people this year at their Pennsylvania-based locations, according to notices filed with the Pennsylvania Department of Labor and Industry.
FDA approves Impax's AB rated generic Concerta Extended-Release Tablets CII cphi-online
July 19, 2017
Company expects to launch by the end of the year.
Lupin launches generic Vigamox Ophthalmic solution in the US financialexpress
July 06, 2017
The product is being manufactured at the company’s Pithampur facility
62% of medicines dispensed in Europe are generic, says new IMS data europeanpharmaceuticalreview
July 03, 2017
New IMS data reveals the growing importance of generic medicines for public health as they now account for 62% of medicines dispensed in Europe delivering huge value while impacting only 4% of total healthcare budgets.
62% of medicines dispensed in Europe are generic, says new IMS data europeanpharmaceuticalreview
July 03, 2017
New IMS data reveals the growing importance of generic medicines for public health as they now account for 62% of medicines dispensed in Europe delivering huge value while impacting only 4% of total healthcare budgets.
Vectura links with Novartis for inhaled asthma/COPD generic pharmatimes
June 30, 2017
Vectura links with Novartis for inhaled asthma/COPD generic
USFDA approves the generic version of Lialda of an Indian drug firm Zydus Cadila biospectrumasia
June 15, 2017
The generic version of Lialda presents a significant opportunity for the Gujarat-based firm Zydus Cadila in the US.
Pharmadax Receives FDA Approval for Generic Version of Seroquel XR americanpharmaceuticalreview
May 18, 2017
Pharmadax announced the U.S. Food and Drug Administration (FDA) has approved a generic equivalent to Seroquel XR (quetiapine fumarate) ER tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.
Allow co-prescription of brands and generic: IDMA to PM financialexpress
May 10, 2017
Says branded and generics markets can complement and supplement each other
Hetero receives generic ‘Sofosbuvir+Velpatasvir’ approval from DCG(I) financialexpress
May 09, 2017
The product will be marketed and distributed under the brand name ‘Velasof’ in India

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page